Evidence map›Paper›PMID 38388704›Full record

ArticleMolecular psychiatry2024

(R)-ketamine restores anterior insular cortex activity and cognitive deficits in social isolation-reared mice.

Rei Yokoyama, Yukio Ago, Hisato Igarashi, Momoko Higuchi, Masato Tanuma, Yuto Shimazaki, Takafumi Kawai, Kaoru Seiriki, Misuzu Hayashida, Shun Yamaguchi and 6 more

Open access · hybridAbstract read
In one paragraph

Article in Molecular psychiatry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Article
  3. Negative allosteric modulation of α5-GABAbioRxiv : the preprint server for biology · 2026
    Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. (International journal of molecular sciences · 2024
    Review
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 7 institutions in 1 country.

Rei Yokoyama *Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka, 565-0871, Japan.
Yukio Ago *Department of Cellular and Molecular Pharmacology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Hiroshima, 734-8553, Japan.ORCID 0000-0001-7562-4000
Hisato IgarashiLaboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka, 565-0871, Japan.
Momoko HiguchiLaboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka, 565-0871, Japan.
Masato TanumaLaboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka, 565-0871, Japan.
Yuto ShimazakiLaboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka, 565-0871, Japan.
Takafumi KawaiLaboratory of Integrative Physiology, Department of Physiology, Graduate School of Medicine, Osaka University, Suita, Osaka, 565-0871, Japan.
Kaoru SeirikiLaboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka, 565-0871, Japan.
Misuzu HayashidaLaboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka, 565-0871, Japan.
Shun YamaguchiDepartment of Morphological Neuroscience, Graduate School of Medicine, Gifu University, Gifu, Gifu, 501-1194, Japan.
Hirokazu TanakaFaculty of Information Technology, Tokyo City University, Setagaya, Tokyo, 158-8557, Japan.
Takanobu NakazawaDepartment of Bioscience, Tokyo University of Agriculture, Setagaya, Tokyo, 156-8502, Japan.ORCID 0000-0003-4863-1277
Yasushi OkamuraLaboratory of Integrative Physiology, Department of Physiology, Graduate School of Medicine, Osaka University, Suita, Osaka, 565-0871, Japan.
Kenji HashimotoDivision of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chuo, Chiba, 260-8670, Japan.
Atsushi KasaiLaboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka, 565-0871, Japan. kasai@phs.osaka-u.ac.jp.ORCID 0000-0002-1612-3078
Hitoshi HashimotoLaboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka, 565-0871, Japan. hasimoto@phs.osaka-u.ac.jp.
The University of Osaka · JPCenter for Forensic Mental Health, Chiba University · JPGifu University · JPHiroshima University · JPOsaka University of Pharmaceutical Sciences · JPTokyo City University · JPTokyo University of Agriculture · JP

Funding

Japan Agency for Medical Research and Development (AMED) JP20dm0107122Japan Agency for Medical Research and Development (AMED) JP21dm0207117Japan Agency for Medical Research and Development (AMED) JP21wm0425017Japan Agency for Medical Research and Development (AMED) JP21wm0525005Japan Agency for Medical Research and Development (AMED) JP22ama121052Japan Agency for Medical Research and Development (AMED) JP22ama121054MEXT | Japan Science and Technology Agency (JST) JPMJFR2061MEXT | Japan Society for the Promotion of Science (JSPS) JP20H00492MEXT | Japan Society for the Promotion of Science (JSPS) JP20H03391MEXT | Japan Society for the Promotion of Science (JSPS) JP20H03392MEXT | Japan Society for the Promotion of Science (JSPS) JP21K19335MEXT | Japan Society for the Promotion of Science (JSPS) JP21K19714MEXT | Japan Society for the Promotion of Science (JSPS) JP22H05080MEXT | Japan Society for the Promotion of Science (JSPS) JP22J13259MEXT | Japan Society for the Promotion of Science (JSPS) JP22KJ2161MEXT | Japan Society for the Promotion of Science (JSPS) JP23H02640MEXT | Japan Society for the Promotion of Science (JSPS) JP23K00395Ministry of Education, Culture, Sports, Science and Technology (MEXT) JP18H05416
6 · The paper itself

Abstract

Chronic social isolation increases the risk of mental health problems, including cognitive impairments and depression. While subanesthetic ketamine is considered effective for cognitive impairments in patients with depression, the neural mechanisms underlying its effects are not well understood. Here we identified unique activation of the anterior insular cortex (aIC) as a characteristic feature in brain-wide regions of mice reared in social isolation and treated with (R)-ketamine, a ketamine enantiomer. Using fiber photometry recording on freely moving mice, we found that social isolation attenuates aIC neuronal activation upon social contact and that (R)-ketamine, but not (S)-ketamine, is able to counteracts this reduction. (R)-ketamine facilitated social cognition in social isolation-reared mice during the social memory test. aIC inactivation offset the effect of (R)-ketamine on social memory. Our results suggest that (R)-ketamine has promising potential as an effective intervention for social cognitive deficits by restoring aIC function.

Indexed as

Cognitive DysfunctionInsular CortexKetamineSocial IsolationAnimalsCerebral CortexCognitionCognition DisordersMaleMemoryMiceMice, Inbred C57BLNeuronsSocial BehaviorKetamine

Identifiers

PMID38388704
PMCPMC11189812
OpenAlexW4392773843

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.